Extended-release pramipexole in advanced Parkinson disease
Links shared publicly online about this topic.
- 37total visits
Extended-release pramipexole in advanced Parkinson disease
View full resource at neurology.org
Tags: Neurology, Parkinson's Disease, Parkinson's Disease Medication, Neuropathic Pain Medication, Disease and Condition, Sifrol, Mirapex, disease
Most Recently Shared on August 29, 2011 at 3:00 pm By:
Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial http://ow.ly/6auka #neurology
Neurology Article | Parkinson Disease
mdlinx.com — “Extended-release pramipexole in early Parkinson disease-A 33-week randomized controlled trial” View full resource at mdlinx.com
Most Recently Shared on August 26, 2011 at 3:40 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Extended-release pramipexole in early Parkinson disease-A 33-week randomized controlled trial: Neurology http://t.co/1pE2m0b #neuro
Extended-release pramipexole in early Parkinson disease
neurology.org — “Extended-release pramipexole in early Parkinson disease” View full resource at neurology.org
Most Recently Shared on August 26, 2011 at 2:55 pm By:
Neurology Journal Medical Journal and Neurology
Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial http://ow.ly/6augC #neurology
Neurology Article | Parkinson Disease
mdlinx.com — “Extended-release pramipexole in advanced Parkinson disease- A randomized controlled trial” View full resource at mdlinx.com
Most Recently Shared on August 23, 2011 at 12:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Extended-release pramipexole in advanced Parkinson disease- A randomized controlled trial: Neurology http://t.co/SdhjGwI #neuro
Phase 3 Study of IPX066 for Advanced Parkinson's Disease - MPR
empr.com — “Impax Pharmaceuticals and GlaxoSmithKline announced positive topline results from its Phase 3 ASCEND-PD trial investigating IPX066 (carbidopa-levodopa extended release capsule) for the treatment of advanced Parksinon’s disease.” View full resource at empr.com
Most Recently Shared on August 15, 2011 at 6:30 pm By:
Phase 3 Study of IPX066 for Advanced Parkinson's Disease http://t.co/ROhzjfj #parkinsons
Phase 3 Study of IPX066 for Advanced Parkinson's Disease - MPR
empr.com — “Impax Pharmaceuticals announced positive results from its Phase 3 ADVANCE-PD study of IPX066 (extended-release carbidopa-levodopa) versus immediate-release carbidopa-levodopa in advanced Parkinson--™s disease patients.” View full resource at empr.com
Most Recently Shared on March 15, 2011 at 2:48 pm By:
MPR News: Phase 3 Study of IPX066 for Advanced Parkinson's Disease: Impax Pharmaceuticals announced positive res... http://bit.ly/gzXJKA
Impax Pharmaceuticals completes enrollment in IPX066 Phase III trial for Parkinson's disease
news-medical.net — “Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical sympt” View full resource at news-medical.net
Most Recently Shared on August 26, 2010 at 6:42 am By:
Impax Pharmaceuticals completes enrollment in IPX066 Phase III trial for Parkinson’s disease: Impax Pharmaceutical... http://bit.ly/9zTMIF
Psychiatry Medical News about Parkinson Disease Pramipexole
mdlinx.com — “Pramipexole Extended Release: In Parkinson's Disease” View full resource at mdlinx.com
Most Recently Shared on April 14, 2010 at 4:42 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pramipexole Extended Release: In Parkinson's Disease: CNS Drugs http://bit.ly/9aAO2j #PSY
FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.” View full resource at news-medical.net
Most Recently Shared on March 26, 2010 at 11:38 am By:
Parkinson's Disease: FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD: Boehringer Ingelheim... http://bit.ly/9ct9qR
Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
drugs.com — “Mirapex ER (pramipexole dihydrochloride) is used to treat Early and Advanced Parkinson's Disease. Includes Mirapex ER side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 24, 2010 at 10:27 pm By:
Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease - http://bit.ly/buiaNc
Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablet” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2010 at 12:37 pm By:
Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease Boehringer Ingelheim Pharma.. http://bit.ly/ahPstx
Mirapex ER approved for advanced Parkinson's Disease - ONA
oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer Ingelheim) for the signs and symptoms of advanced idiopathic Parkinson--™s disease (PD).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 23, 2010 at 3:59 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Mirapex ER approved for advanced Parkinson's Disease http://goo.gl/fb/FEnz
Extended-Release Mirapex Approved for Parkinson's Disease - Yahoo! News
us.rd.yahoo.com — “WEDNESDAY, Feb. 24 (HealthDay News) -- Mirapex ER (pramipexole dihydrochloride extended-release) has been approved by the U.S. Food and Drug Administration as a once-daily option to treat early Parkinson's disease, drug maker Boehringer Ingelheim said in a news release.” View full resource at us.rd.yahoo.com
Most Recently Shared on February 24, 2010 at 5:28 pm By:
Extended-Release Mirapex Approved for Parkinson's Disease (HealthDay) http://bit.ly/a2AFKd
Medical News: FDA Okays Once-Daily Parkinson's Drug - in Neurology, Parkinson's Disease from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved an extended release version of pramipexole (Mirapex ER) for patients with early Parkinson's disease.” View full resource at medpagetoday.com
Most Recently Shared on February 24, 2010 at 4:07 pm By:
FDA Okays Once-Daily Parkinson's Drug WASHINGTON (MedPage Today) -- The FDA has approved an extended release version .. http://bit.ly/aP4x1P
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new on” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 2:11 pm By:
MNT Parkinson's News Health News
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease http://mnt.to/3xY5 #parkinsons
Advertisement
